SNS Financial Group’s Pfizer PFE Stock Holding History

SNS Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$356K	Buy	12,665 +16	+0.1%	+$426	0.03%	155
2025 Q4	$315K	Sell	12,649 -1,763	-12%	-$44.5K	0.03%	167
2025 Q3	$367K	Sell	14,412 -196	-1%	-$4.84K	0.03%	147
2025 Q2	$354K	Sell	14,608 -1,038	-7%	-$24.2K	0.03%	142
2025 Q1	$396K	Buy	15,646 +2,662	+21%	+$69.7K	0.04%	129
2024 Q4	$344K	Sell	12,984 -1,140	-8%	-$30.9K	0.04%	133
2024 Q3	$409K	Sell	14,124 -5,854	-29%	-$171K	0.04%	127
2024 Q2	$559K	Sell	19,978 -35,992	-64%	-$991K	0.06%	111
2024 Q1	$1.55M	Sell	55,970 -2,598	-4%	-$72.1K	0.17%	60
2023 Q4	$1.69M	Buy	58,568 +932	+2%	+$28.2K	0.2%	55
2023 Q3	$1.91M	Sell	57,636 -7,591	-12%	-$268K	0.25%	48
2023 Q2	$2.39M	Buy	65,227 +564	+0.9%	+$22K	0.31%	42
2023 Q1	$2.64M	Buy	64,663 +14,951	+30%	+$646K	0.35%	42
2022 Q4	$2.55M	Sell	49,712 -14,776	-23%	-$708K	0.34%	47
2022 Q3	$2.82M	Sell	64,488 -1,345	-2%	-$65.4K	0.41%	42
2022 Q2	$3.45M	Sell	65,833 -1,254	-2%	-$63.9K	0.45%	38
2022 Q1	$3.47M	Buy	67,087 +28,262	+73%	+$1.47M	0.39%	45
2021 Q4	$2.29M	Sell	38,825 -878	-2%	-$43.5K	0.24%	61
2021 Q3	$1.71M	Sell	39,703 -56,486	-59%	-$2.5M	0.21%	68
2021 Q2	$3.77M	Sell	96,189 -747	-0.8%	-$29K	0.48%	38
2021 Q1	$3.51M	Buy	96,936 +1,286	+1%	+$45.7K	0.47%	42
2020 Q4	$3.52M	Sell	95,650 -5,328	-5%	-$195K	0.5%	35
2020 Q3	$3.52M	Sell	100,978 -6,336	-6%	-$222K	0.55%	32
2020 Q2	$3.33M	Sell	107,314 -2,898	-3%	-$98.5K	0.6%	31
2020 Q1	$3.41M	Sell	110,212 -4,515	-4%	-$154K	0.65%	31
2019 Q4	$4.26M	Sell	114,727 -567	-0.5%	-$20.2K	0.75%	25
2019 Q3	$3.93M	Sell	115,294 -1,556	-1%	-$56.6K	0.75%	25
2019 Q2	$4.8M	Sell	116,850 -2,592	-2%	-$103K	0.9%	25
2019 Q1	$4.81M	Buy	119,442 +398	+0.3%	+$15.9K	1.06%	24
2018 Q4	$4.93M	Buy	119,044 +3,128	+3%	+$130K	1.22%	23
2018 Q3	$4.85M	Sell	115,916 -2,431	-2%	-$93.6K	1.16%	21
2018 Q2	$4.07M	Sell	118,347 -1,310	-1%	-$44.8K	1.07%	23
2018 Q1	$4.03M	Sell	119,657 -20,553	-15%	-$707K	1.1%	22
2017 Q4	$4.82M	Sell	140,210 -9,998	-7%	-$341K	1.16%	26
2017 Q3	$5.09M	Sell	150,208 -11,171	-7%	-$359K	1.3%	22
2017 Q2	$5.14M	Sell	161,379 -11,633	-7%	-$367K	1.37%	19
2017 Q1	$5.62M	Sell	173,012 -49,832	-22%	-$1.57M	1.44%	15
2016 Q4	$6.87M	Buy	222,844 +201,019	+921%	+$6.14M	2.02%	11
2016 Q3	$701K	Buy	21,825 +1,810	+9%	+$60.5K	0.2%	69
2016 Q2	$669K	Sell	20,015 -47,840	-71%	-$1.53M	0.17%	74
2016 Q1	$1.91M	Buy	67,855 +2,290	+3%	+$65.4K	0.49%	31
2015 Q4	$2.01M	Buy	65,565 +5,472	+9%	+$172K	0.5%	31
2015 Q3	$1.79M	Sell	60,093 -101	-0.2%	-$3.24K	0.49%	30
2015 Q2	$1.92M	Buy	60,194 +7,350	+14%	+$240K	0.58%	38
2015 Q1	$1.74M	Buy	52,844 +6,124	+13%	+$195K	0.64%	37
2014 Q4	$1.38M	Buy	46,720 +13,417	+40%	+$385K	0.55%	39
2014 Q3	$934K	Buy	33,303 +7,714	+30%	+$217K	0.31%	46
2014 Q2	$721K	Buy	25,589 +7,492	+41%	+$214K	0.29%	50
2014 Q1	$552K	Buy	18,097 +3,396	+23%	+$101K	0.25%	49
2013 Q4	$427K	Buy	+14,701	New	+$428K	0.2%	83

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SNS Financial Group's PFE Position: Q1 2026 in Review

SNS Financial Group increased its Pfizer (PFE) stake by 0.13% in Q1 2026, buying an estimated $426 and bringing the position to 12,665 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #155.

SNS Financial Group first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $6.87M in Q4 2016. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

SNS Financial Group held 12,665 shares of Pfizer worth $356K as of Q1 2026.
SNS Financial Group bought 16 Pfizer shares in Q1 2026, an estimated $426.
Pfizer made up 0.03% of SNS Financial Group's portfolio in Q1 2026, its #155 holding.
SNS Financial Group first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
SNS Financial Group's Pfizer position peaked at $6.87M in Q4 2016.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.